Reuters logo
6 months ago
BRIEF-Ariad announces submission of marketing authorization application for Brigatinib
February 6, 2017 / 1:03 PM / 6 months ago

BRIEF-Ariad announces submission of marketing authorization application for Brigatinib

Feb 6 (Reuters) - Ariad Pharmaceuticals Inc

* Ariad announces submission of marketing authorization application for Brigatinib to the European Medicines Agency

* FDA currently reviewing a NDA for Brigatinib filed by co,set action date of April 29, 2017 under prescription drug user fee act Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below